Evidence map›Paper›PMID 24968072›Full record

ArticleJournal of immunological methods2014

Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays.

Janet S Staats, Jennifer H Enzor, Ana M Sanchez, Wes Rountree, Cliburn Chan, Maria Jaimes, Ray Chun-Fai Chan, Amitabh Gaur, Thomas N Denny, Kent J Weinhold

Abstract read
In one paragraph

Article in Journal of immunological methods, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Cytometrist's Guide to Coordinating and Performing Effective COVID-19 Research.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2021
    Review
  7. Immune Monitoring for CMV in Transplantation.Current infectious disease reports · 2018
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Janet S StaatsDuke Center for AIDS Research, Duke University, Durham, NC, USA; Duke External Quality Assurance Program Oversight Laboratory, Duke University, Durham, NC, USA; Department of Surgery, Duke University Medical Center, Durham, NC, USA. Electronic address: janet.staats@dm.duke.edu.
Jennifer H EnzorDuke Center for AIDS Research, Duke University, Durham, NC, USA; Duke External Quality Assurance Program Oversight Laboratory, Duke University, Durham, NC, USA; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Ana M SanchezDuke External Quality Assurance Program Oversight Laboratory, Duke University, Durham, NC, USA; Department of Medicine, Duke University Medical Center, Durham, NC, USA; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
Wes RountreeDuke External Quality Assurance Program Oversight Laboratory, Duke University, Durham, NC, USA; Department of Medicine, Duke University Medical Center, Durham, NC, USA; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
Cliburn ChanDuke Center for AIDS Research, Duke University, Durham, NC, USA; Duke External Quality Assurance Program Oversight Laboratory, Duke University, Durham, NC, USA; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
Maria JaimesBD Biosciences, San Jose, CA, USA.
Ray Chun-Fai ChanCustom Technology Team, BD Biosciences, San Diego, CA, USA.
Amitabh GaurCustom Technology Team, BD Biosciences, San Diego, CA, USA.
Thomas N DennyDuke External Quality Assurance Program Oversight Laboratory, Duke University, Durham, NC, USA; Department of Medicine, Duke University Medical Center, Durham, NC, USA; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
Kent J WeinholdDuke Center for AIDS Research, Duke University, Durham, NC, USA; Duke External Quality Assurance Program Oversight Laboratory, Duke University, Durham, NC, USA; Department of Surgery, Duke University Medical Center, Durham, NC, USA.

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
NIAID NIH HHS 5P30 AI064518NIAID NIH HHS HHSN272201000045CNIAID NIH HHS P30 AI064518
6 · The paper itself

Abstract

The External Quality Assurance Program Oversight Laboratory (EQAPOL) Flow Cytometry Program assesses the proficiency of NIH/NIAID/DAIDS-supported and potentially other interested research laboratories in performing Intracellular Cytokine Staining (ICS) assays. The goal of the EQAPOL Flow Cytometry External Quality Assurance Program (EQAP) is to provide proficiency testing and remediation for participating sites. The program is not punitive; rather, EQAPOL aims to help sites identify areas for improvement. EQAPOL utilizes a highly standardized ICS assay to minimize variability and readily identify those sites experiencing technical difficulties with their assays. Here, we report the results of External Proficiency 3 (EP3) where participating sites performed a 7-color ICS assay. On average, sites perform well in the Flow Cytometry EQAP (median score is "Good"). The most common technical issues identified by the program involve protocol adherence and data analysis; these areas have been the focus of site remediation. The EQAPOL Flow Cytometry team is now in the process of expanding the program to 8-color ICS assays. Evaluating polyfunctional ICS responses would align the program with assays currently being performed in support of HIV immune monitoring assays.

Indexed as

BiomarkersConsensusCooperative BehaviorCytokinesFlow CytometryGuideline AdherenceHIV InfectionsHumansInternational CooperationLaboratoriesLaboratory Proficiency TestingMonitoring, ImmunologicMulticenter Studies as TopicObserver VariationPractice Guidelines as TopicPredictive Value of TestsBiomarkersCytokinesAntigen specificFlow cytometryGradingICSProficiency testingSite performance

Identifiers

PMID24968072
PMCPMC4138230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.